Analysis of Emerging Tumor Markers and Strategic Profiles of Leading Suppliers

September 2012 | 286 pages | ID: AA9A78D6ED4EN
Venture Planning Group

Abstracts

This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

The report includes an overview of the clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing or marketing innovative technologies, products, and applications.

The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 286 pages and 28 tables

Synopsis

"This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others."

Contents

MAJOR CURRENT AND EMERGING CANCER DIAGNOSTIC TESTS

1. Introduction
2. Tumor Marker Classification
3. ACTH
4. Alpha-Fetoprotein (AFP)
5. Beta-2 Microglobulin
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. NSE
17. Occult Blood
18. PAP Smear/HPV
19. Prostatic Acid Phosphatase (PAP)
20. Prostate-Specific Antigen (PSA)
21. Squamous Cell Carcinoma Antigen (SCC)
22. T and B Lymphocytes
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
  - ADA
  - B-Protein
  - PNP
  - 5'-Nucleotidase
27. Oncogenes
  - Abl/abl-bcr
  - AIB1
  - BCL-2
  - BRCA1
  - CD44
  - C-fos
  - C-myb
  - C-myc
  - CYP-17
  - Erb-B
  - HPC1
  - N-myc
  - P40
  - P51
  - P53
  - PIK3CA
  - PTI-1
  - Ras
  - Reg
  - Sis
  - Src
28. Polypeptide Growth Factors
  - Basic Fibroblast Growth Factor
  - Beta-TGF
  - Cachectin (TNT)
  - Calmodulin
  - ECFR
  - Nerve Growth Factor (NGF)
  - Epidermal Growth Factor (EGF)
  - Ornithine Decarboxylase
  - Transferrin
  - Transforming Growth Factor-Alpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
  - Alpha-Interferon
  - B Cell Growth Factors
  - B Cell Growth Factor (BCGF)
  - Gamma-Interferon
  - Interleukin-1 (IL-1)
  - Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
  - N-Acetylglucosamine
  - Actin
  - Alpha-Actin
  - Antineuronal Antibodies
  - 7B2
  - B72.3
  - Bax
  - BCD-F9
  - BLCA-4
  - Blood Group Antigens A,B,H
  - CA 50
  - CA 72-4/TAG-72
  - CA 195
  - CA-242
  - CA-549
  - CAM 26
  - CAR-3
  - Cathepsin-D
  - Chromogranin A and B
  - Cluster 1 Antigen
  - Cluster-5/5A Antigen
  - CTA
  - CU18
  - DR-70
  - DU-PAN-2
  - Endometrial Bleeding Associated Factor
  - Endostatin
  - Epithelial Membrane Antigen
  - Feulgen Hydrolysis
  - Fibronectin
  - FSH
  - (1->3)-L-fucosyltransferase
  - Gastrin-Releasing Peptide (GRP)
  - GDCFP-15
  - Glucagon
  - Glycoamines
  - H23
  - Her-2
  - Human Carcinoma Antigen
  - HPA
  - HSP27
  - Intermediate Filaments
  - Cytokeratins/CK18/Cyfra 21-1
  - Desmin
  - Gliofibrillary Acid Protein
  - Neurofilaments
  - Vimentin
  - KA 93
  - Kinases
  - KP16D3
  - LAI
  - Leukocyte Common Antigen
  - Lewis Antigens
  - Lysophosphatidic Acid (LPA)
  - Ma 695/Ma 552
  - MABDF3
  - MAG
  - ME1
  - Minactivin
  - MN/CA9
  - MSA
  - Mucin Cancer Antigen (MCA)
  - Multiple Tumor Suppressor 1
  - Myosin
  - NEA-130
  - NMP22
  - OA-519
  - Opiod Peptides
  - P-glycoprotein
  - Pancreatic Oncofetal Antigen (POA)
  - Placental Lactogen
  - PR92
  - Proliferative Index, Ki-67
  - Px
  - RB Inactivation/Deletion
  - Ret
  - SCCL 175
  - Selectin
  - Sialic Acid
  - Sialyl SSEA-1/SLX
  - SN10
  - Somatostatin
  - TA-90
  - TABA
  - Tachykinin
  - TAG 12
  - TPS
  - Troponin
  - Tubulin
  - VCAM
  - VEGF
  - Villen

COMPETITIVE PROFILES

- Abbott
- AdnaGen
- Applied Gene Technologies
- Arca
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- Cepheid
- Correlogic Systems
- Dako
- Decode
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Gen-Probe
- Guided Therapeutics
- Hologic
- Ipsogen
- Kreatech
- Kyowa Medex
- Life Technologies
- Mackay Life Sciences
- Myriad Genetics
- Nanogen Elitech
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

APPENDIXES

Appendix I:
  Major Universities and Research
  Centers Developing Cancer Diagnostic
  Technology and Applications

List Of Tables

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis